SCHEMBL8843572

SCHEMBL8843572

CC(CC(=O)OC(=O)C(F)(F)F)N1CC(=O)N(Cc2ccccc2)c2ccc(CCSCCN)cc2C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 8/20 0.34
ITGB3 P05106 4/20 0.34
ITGA2B P08514 4/20 0.34
CHRM5 P08912 3/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
TRPA1 O75762 1/20 0.31
PRKAG1 P54619 1/20 0.30
PRKAA1 Q13131 1/20 0.30
PRKAB1 Q9Y478 1/20 0.30
MDH2 P40926 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8842967 0.91 MEN1 (0.33) PTGDR2CHRM5HDAC3HDAC4HDAC1
SCHEMBL7331333 0.90 PTGDR2 (0.35) PTGDR2ITGB3ITGA2BCHRM5HDAC3
SCHEMBL8842957 0.89 ITGB3 (0.34) ITGB3ITGA2B
SCHEMBL7334770 0.86 PTGDR2 (0.34) PTGDR2ITGB3ITGA2BCHRM5HDAC3
SCHEMBL7330483 0.83 ITGB3 (0.36) PTGDR2ITGB3ITGA2B
SCHEMBL7331728 0.82 HDAC3 (0.37) PTGDR2ITGB3ITGA2BHDAC3HDAC4
SCHEMBL7330721 0.82 ITGB3 (0.36) PTGDR2ITGB3ITGA2B
SCHEMBL7321630 0.82 ITGB3 (0.41) PTGDR2ITGB3ITGA2BHDAC1HDAC6
SCHEMBL7335036 0.82 ITGB3 (0.45) PTGDR2ITGB3ITGA2BPRKAG1PRKAA1
SCHEMBL9009482 0.82 PTGDR2 (0.34) PTGDR2ITGB3ITGA2BCHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed